Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. (Record no. 10573593)

MARC details
000 -LEADER
fixed length control field 01564 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513200919.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200004s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0271-3683
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1076/0271-3683(200002)20:2;1-d;ft085
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name De Saint Jean, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000405
245 00 - TITLE STATEMENT
Title Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current eye research
Date of publication, distribution, etc. Feb 2000
300 ## - PHYSICAL DESCRIPTION
Extent 85-94 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenergic beta-Antagonists
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzalkonium Compounds
General subdivision toxicity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Count
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Survival
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chromatin
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Conjunctiva
General subdivision cytology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Flow Cytometry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Free Radicals
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glaucoma
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydrogen Peroxide
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Preservatives, Pharmaceutical
General subdivision toxicity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Timolol
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Toxicity Tests
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Debbasch, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brignole, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rat, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Warnet, J M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baudouin, C
773 0# - HOST ITEM ENTRY
Title Current eye research
Related parts vol. 20
-- no. 2
-- p. 85-94
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1076/0271-3683(200002)20:2;1-d;ft085">https://doi.org/10.1076/0271-3683(200002)20:2;1-d;ft085</a>
Public note Available from publisher's website

No items available.